Pharmacy Group
RSS Feeds Peertechz

International Journal of Pharmaceutical Sciences and Developmental Research  Open Access

ISSN: 2640-7760


    Open Access Editorial Article ID: IJPSDR-1-101

    Heat Shock Protein 90 c-Terminal Inhibitors in Cancer Treatment

    Yusuf Tutar*

    Heat shock protein 90 (Hsp90) is 90 kDa highly conserved dimeric chaperone protein in prokaryotic and eukaryotic cells and it is localized in different parts of the cell. Hsp90AA1 (inducible) and Hsp90AB1 (constitutive) are available in the cytosol; Grp94 and TRAP1 exist in endoplasmic reticulum and mitochondria; respectively. In unstressed cells, expression level of Hsp90 corresponds to 1-2% of total cellular protein, and Hsp90 is responsible for protein folding, maintenance and degradation of misfolded proteins, cell cycle control, and cellular signaling. Hsp90 is composed of three domains: N terminal domain (NTD), middle domain (MD), and C terminal domain (CTD). Hsp90 needs ATP hydrolysis energy to perform chaperone functions. NTD has ATP binding sites and ATP hydrolysis leads to large conformational changes for interaction between substrate proteins and Hsp90. CTD contains a conserved EEVD motif and the dimerization interface to regulate ATPase process and binding of co-chaperones (i.e. Hop, CHIP) in protein folding process [1-3].


    Published on: May 16, 2015 Pages: 1-1

    Full Text PDF Full Text HTML DOI: 10.17352/ijpsdr.000001 CrossMark

    Find more...

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR